Picture of Optomed Oyj logo

OPTOMED Optomed Oyj Share Price

0.000.00%
fi flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m+12.02%
3m+6.42%
6m+29.87%
1yr-14.71%
Volume Change (%)
10d/3m-0.92%
Price vs... (%)
52w High-11.55%
50d MA+5.68%
200d MA+22.8%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-16.54%
Return on Equity-21.82%
Operating Margin-26.32%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Optomed Oyj EPS forecast chart

Profile Summary

Optomed Oyj is a Finland-based medical technology company and a producer of handheld fundus cameras globally. The Group's Parent Company, Optomed Oyj, is responsible for, among other things, the management of the Group as well as finance and accounting functions, human resources, legal affairs and corporate communication. The Group's business is managed through two reportable segments: Devices and Software. The Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras. The Software segment develops and sells screening software for diabetic retinopathy and cancer screening for healthcare organizations. The Optomed Group consists of the parent company Optomed Oyj and four subsidiaries in Finland, China, the USA and Hong Kong.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
December 31st, 2004
Public Since
December 9th, 2019
No. of Shareholders
9,535
No. of Employees
114
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
fi flag iconOMX Nordic Exchange - Helsinki
Shares in Issue
17,776,424

OPTOMED Share Price Performance

Upcoming Events for OPTOMED

Q1 2024 Optomed Oyj Earnings Release

Optomed Oyj Annual Shareholders Meeting

Q2 2024 Optomed Oyj Earnings Release

Half Year 2024 Optomed Oyj Earnings Release

Similar to OPTOMED

Picture of BBS-Bioactive Bone Substitutes Oyj logo

BBS-Bioactive Bone Substitutes Oyj

fi flag iconOMX Nordic Exchange - Helsinki

Picture of Bioretec Oy logo

Bioretec Oy

fi flag iconOMX Nordic Exchange - Helsinki

Picture of Modulight Oyj logo

Modulight Oyj

fi flag iconOMX Nordic Exchange - Helsinki

Picture of Nexstim Oyj logo

Nexstim Oyj

fi flag iconOMX Nordic Exchange - Helsinki

Picture of Nightingale Health Oyj logo

Nightingale Health Oyj

fi flag iconOMX Nordic Exchange - Helsinki

FAQ